| NCT ID | NCT06598189 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Felicia Chu |
| Condition | Seizures |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-04-03 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-04-03 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The proposed study is an investigator-initiated study that aims to measure the accuracy of a wearable seizure detection and prediction device (Ear-Seizure Detection Device (EarSD)) by simultaneous recording with conventional video-EEG (Electroencephalogram) on patients with epileptic seizures in the Epilepsy Monitoring Unit of the hospital.
Eligibility Criteria
Inclusion Criteria: 1. Age ≥ 18 years. 2. Patients admitted to UMass Memorial Epilepsy Monitoring Unit (EMU) for long term video-EEG monitoring as part of standard care of both focal and generalized epilepsy. 3. Willing to wear the wearable device. 4. Ability to provide informed consent Exclusion Criteria: 1. Subjects wearing other ear devices such as hearing aids. 2. Inability or unwillingness to provide informed consent. 3. Irritation of the skin where the device is to be placed. 4. Patients with intracranial electrodes placement. 5. Prisoners 6. Cognitive impaired individuals 7. Pregnant Women 8. Children (Age 0-17)
Contact & Investigator
Felicia Chu, MD
PRINCIPAL INVESTIGATOR
UMass Neurology Department
Frequently Asked Questions
Who can join the NCT06598189 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Seizures. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06598189 currently recruiting?
Yes, NCT06598189 is actively recruiting participants. Contact the research team at Stephanie.Stephens1@umassmed.edu for enrollment information.
Where is the NCT06598189 trial being conducted?
This trial is being conducted at Worcester, United States, Worcester, United States.
Who is sponsoring the NCT06598189 clinical trial?
NCT06598189 is sponsored by Felicia Chu. The principal investigator is Felicia Chu, MD at UMass Neurology Department. The trial plans to enroll 40 participants.